DexCom, Inc.

DXCM

$78.19

Name : DexCom, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $30,171,410,432.00

EPSttm : 2.33

DexCom, Inc.

$78.19

2.05%

$1.57

DXCM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.63

Margin Of Safety %

-19

Put/Call OI Ratio

1.01

EPS Next Q Diff

0.11

EPS Last/This Y

0.45

EPS This/Next Y

0.48

Price

78.19

Target Price

84.5

Analyst Recom

1.39

Performance Q

15.34

Upside

4.7%

Beta

1.42

Ticker: DXCM

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	DXCM	59.33	1.05	2.51	97941
2026-05-12	DXCM	61.13	1.07	1.11	100923
2026-05-13	DXCM	58.55	1.07	0.56	102589
2026-05-14	DXCM	57.82	1.06	0.35	103498
2026-05-15	DXCM	61.64	1.00	0.39	106855
2026-05-18	DXCM	65.12	1.11	0.43	90119
2026-05-19	DXCM	66.94	1.09	1.35	92293
2026-05-20	DXCM	71.45	1.08	0.24	93732
2026-05-21	DXCM	71.98	1.03	1.10	96853
2026-05-22	DXCM	72.11	1.05	0.25	97903
2026-05-26	DXCM	72.02	1.05	0.96	94601
2026-05-27	DXCM	70.25	1.05	2.26	95455
2026-05-28	DXCM	72.35	1.04	0.29	95664
2026-05-29	DXCM	73.74	0.98	0.21	99311
2026-06-02	DXCM	73.41	0.97	1.01	99467
2026-06-03	DXCM	72.77	0.98	1.10	99877
2026-06-04	DXCM	72.59	0.97	2.17	100834
2026-06-05	DXCM	72.87	1.00	0.40	103288
2026-06-08	DXCM	76.59	1.05	0.27	99961
2026-06-09	DXCM	78.19	1.01	0.32	102498
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	DXCM	59.36	26.5	-163.1	2.58
2026-05-12	DXCM	61.11	26.5	-105.8	2.58
2026-05-13	DXCM	58.54	26.5	-187.7	2.58
2026-05-14	DXCM	57.81	26.5	-154.3	2.58
2026-05-15	DXCM	61.65	26.5	-64.8	2.58
2026-05-18	DXCM	65.12	26.5	-75.8	2.58
2026-05-19	DXCM	66.93	26.5	-108.4	2.58
2026-05-20	DXCM	71.46	26.3	-64.0	2.58
2026-05-21	DXCM	71.88	26.3	-132.9	2.58
2026-05-22	DXCM	72.13	26.4	-136.3	2.59
2026-05-26	DXCM	72.03	26.4	-151.6	2.59
2026-05-27	DXCM	70.25	26.4	-177.5	2.59
2026-05-28	DXCM	72.36	26.4	-117.1	2.59
2026-05-29	DXCM	73.77	26.4	-128.6	2.59
2026-06-01	DXCM	74.86	26.6	-133.4	2.59
2026-06-02	DXCM	73.40	26.6	-172.0	2.59
2026-06-03	DXCM	72.74	26.7	-161.0	2.59
2026-06-04	DXCM	72.57	26.7	-152.8	2.59
2026-06-05	DXCM	72.85	26.7	-146.3	2.59
2026-06-08	DXCM	76.62	26.7	-93.0	2.59
2026-06-09	DXCM	78.19	26.7	-127.6	2.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	DXCM	-0.11	-1.84	4.02
2026-05-12	DXCM	-0.11	-1.84	4.85
2026-05-13	DXCM	-0.09	-1.84	4.85
2026-05-14	DXCM	-0.09	-1.84	4.85
2026-05-15	DXCM	-0.11	-1.84	4.85
2026-05-18	DXCM	-0.07	-1.41	4.83
2026-05-19	DXCM	-0.09	-1.41	4.83
2026-05-20	DXCM	-0.11	-1.41	4.83
2026-05-21	DXCM	-0.11	-1.41	4.83
2026-05-22	DXCM	-0.11	-1.41	4.83
2026-05-26	DXCM	-0.11	0.51	4.83
2026-05-27	DXCM	-0.53	0.51	4.83
2026-05-28	DXCM	-0.53	0.51	4.63
2026-05-29	DXCM	-0.53	0.51	4.63
2026-06-02	DXCM	-0.53	-0.48	4.63
2026-06-03	DXCM	-0.50	-0.48	4.63
2026-06-04	DXCM	-0.50	-0.48	4.63
2026-06-05	DXCM	-0.50	-0.48	4.63
2026-06-08	DXCM	-0.64	0.66	4.63
2026-06-09	DXCM	-0.64	0.66	4.63
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.56

Avg. EPS Est. Current Quarter

0.61

Avg. EPS Est. Next Quarter

0.67

Insider Transactions

-0.64

Institutional Transactions

0.66

Beta

1.42

Average Sales Estimate Current Quarter

1290

Average Sales Estimate Next Quarter

1337

Fair Value

63.47

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

52.6

Max Drawdown 5-Year %

-66.3

Target Price

84.5

P/E

33.44

Forward P/E

25.33

PEG

1.22

P/S

6.26

P/B

10.2

P/Free Cash Flow

21.11

EPS

2.34

Average EPS Est. Cur. Y

2.59

EPS Next Y. (Est.)

3.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.31

Relative Volume

0.91

Return on Equity vs Sector %

Return on Equity vs Industry %

19.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

-127.6

◆ DXCM Healthcare

$78.19

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

4/25

Volume

7/15

Valuation

9/20

TP/AR

2/10

Options

3/10

RSI

Range 1M

97.4%

Sup Dist

5.9%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

21/25

Growth

21/30

Estimates

6/20

Inst/Vol

6/15

Options

6/10

EPS Yr

23.9%

EPS NY

19.2%

52W%

67.4%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟡 HOLD +14.7% upside

Quality

30/30

Valuation

8/30

Growth

18/25

Stability

7/10

LT Trend

4/5

Upside

+14.7%

Quality

MoS

-19%

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 11000

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DXCM

Latest News

—

Caricamento notizie per DXCM…

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y